Cargando…
A New Synthetic FGF Receptor Antagonist Inhibits Arteriosclerosis in a Mouse Vein Graft Model and Atherosclerosis in Apolipoprotein E-Deficient Mice
OBJECTIVE: The role of fibroblast growth factors (FGFs) in the development of vascular diseases remains incompletely understood. The objective of this study was to examine the effects of a new small-molecule multi-FGF receptor blocker with allosteric properties, SSR128129E, on neointimal proliferati...
Autores principales: | Dol-Gleizes, Frédérique, Delesque-Touchard, Nathalie, Marès, Anne-Marie, Nestor, Anne-Laure, Schaeffer, Paul, Bono, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817113/ https://www.ncbi.nlm.nih.gov/pubmed/24224032 http://dx.doi.org/10.1371/journal.pone.0080027 |
Ejemplares similares
-
Copeptin as a marker of atherosclerosis and arteriosclerosis
por: Schill, Fredrika, et al.
Publicado: (2021) -
Arteriosclerosis
Publicado: (1925) -
Arteriosclerosis
Publicado: (1913) -
Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference?
por: dos Santos, Vanessa Prado, et al.
Publicado: (2021) -
Apolipoprotein A-I vascular gene therapy reduces vein-graft atherosclerosis
por: Bi, Lianxiang, et al.
Publicado: (2023)